Evidence map›Paper›PMID 25278712›Full record

Trial reportWorld journal of gastroenterology2014

Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer.

Adam Durczynski, Anna Kumor, Piotr Hogendorf, Dariusz Szymanski, Piotr Grzelak, Janusz Strzelczyk

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2018
    Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Adam DurczynskiAdam Durczynski, Piotr Hogendorf, Dariusz Szymanski, Janusz Strzelczyk, Department of General and Transplant Surgery, Medical University of Lodz, 90-153 Lodz, Poland.
Anna KumorAdam Durczynski, Piotr Hogendorf, Dariusz Szymanski, Janusz Strzelczyk, Department of General and Transplant Surgery, Medical University of Lodz, 90-153 Lodz, Poland.
Piotr HogendorfAdam Durczynski, Piotr Hogendorf, Dariusz Szymanski, Janusz Strzelczyk, Department of General and Transplant Surgery, Medical University of Lodz, 90-153 Lodz, Poland.
Dariusz SzymanskiAdam Durczynski, Piotr Hogendorf, Dariusz Szymanski, Janusz Strzelczyk, Department of General and Transplant Surgery, Medical University of Lodz, 90-153 Lodz, Poland.
Piotr GrzelakAdam Durczynski, Piotr Hogendorf, Dariusz Szymanski, Janusz Strzelczyk, Department of General and Transplant Surgery, Medical University of Lodz, 90-153 Lodz, Poland.
Janusz StrzelczykAdam Durczynski, Piotr Hogendorf, Dariusz Szymanski, Janusz Strzelczyk, Department of General and Transplant Surgery, Medical University of Lodz, 90-153 Lodz, Poland.
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo assess the value of D-dimer level in determining resectability of pancreatic cancer.

methodsPreoperative prediction of pancreatic head cancer resectability remains inaccurate. The use of hemostatic factors may be of potential help, since D-dimers correlate with tumor stage. Single center clinical trial study comprised patients with potentially resectable pancreatic head tumor and without detectable venous thrombosis (n = 64). Resectability was defined as no evidence of nodal involvement, distant spread and no invasion of mesenteric vessels. Final decision of resectability was confirmed intraoperatively. Experienced pancreatic surgeon performed all surgeries. Following the dissection of hepatoduodenal ligament, samples of portal blood and bile were taken. Peripheral blood via central line and urine via Foley catheter were sampled. D-dimer levels were further measured.

resultsAt laparotomy only 29 (45.3%) tumors were found to be resectable. Our analysis showed higher by 57.5% (P < 0.001) mean D-dimer values in peripheral and 43.7% (P = 0.035) in portal blood of patients with unresectable pancreatic cancer. Significant differences were not observed when analyzing D-dimer levels in bile and urine. Peripheral D-dimer level correlated with pancreatic cancer resectability. When cut-off D-dimer value of 570.6 μg/L was used, the sensitivity for assessment of tumor unresectability was 82.8%. Furthermore, D-dimer level in peripheral blood of metastatic disease (n = 15) was significantly higher when compared to locally advanced (n = 20) pancreatic cancer (2470 vs 1168, P = 0.029). The area under ROC curve for this subgroup of patients was 0.87; for determination of unresectable disease when threshold of 769.8 μg/L was used, sensitivity and specificity was 86.6% and 80%, respectively.

conclusionPatients with resectable pancreatic head cancer based on preoperative imaging studies and high D-dimer level may be considered unresectable due to occult hepatic metastases. These patients may benefit from diagnostic laparoscopy to avoid exploratory laparotomy.

Indexed as

PancreaticoduodenectomyAdenocarcinomaArea Under CurveBiomarkers, TumorContraindicationsFibrin Fibrinogen Degradation ProductsHumansLiver NeoplasmsNeoplasm StagingPancreatic NeoplasmsPatient SelectionPredictive Value of TestsRisk FactorsROC CurveTomography, Spiral ComputedUltrasonography, DopplerBiomarkers, TumorFibrin Fibrinogen Degradation Productsfibrin fragment DBileD-dimersPancreatic cancerPancreatic cancer respectabilityPeripheral bloodPortal bloodUrine

Identifiers

PMID25278712
PMCPMC4177497
OpenAlexW2034256530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.